New shot aims to protect against deadly meningitis strains

NCT ID NCT07204457

Recruiting now ⭐️ VACCINE ⭐️ Sponsor: EyeGene Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing a new vaccine designed to protect against four types of meningococcal bacteria that can cause serious infections like meningitis. Researchers are comparing this new vaccine to an existing one in about 1,100 healthy adults to see if it triggers a strong immune response and is safe. The goal is to see if this new option works as well as or better than current vaccines.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MENINGOCOCCAL INFECTIONS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

The Catholic University of Eunpyeong St.Mary's Hospital
RECRUITING

Seoul, South Korea

Conditions

Explore the condition pages connected to this study.

MENINGOCOCCAL INFECTIONS